Quick Heal Technologies Limited — Interim / Quarterly Report 2021

Nov 30, 2020

Quick Heal Technologies Ltd.

Sssss

Regd. Office: Marvel Edge, Office No. 7010 C & D, 7th Floor, Opposite Neco Garden Society, Viman Nagar, Pune 411014. Tel: +91 20 66813232 | Email: info@quickheal.com CIN - L72200MH1995PLC091408

Ref. No.: QHTL/Sec/SE/2020-21/46

Ref. No.: QHTL/Sec/SE/2020-21/46 November 30, 2020 The Manager, The Manager, Corporate Services, Corporate Services, BSE Limited, National Stock Exchange of India Limited, 14th floor, P J Towers, Dalal Street, Exchange Plaza, Bandra Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Ref: Security ID : QUICKHEAL Symbol: QUICKHEAL Security Code: 539678 Series : EQ

Dear Sir/Madam,

Sub: Related Party Transaction for the Half Year ended September 30, 2020

Pursuant to regulation 23(9) of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 and other applicable regulations, if any, the disclosures of related party transactions on a consolidated basis for the half year ended September 30, 2020 are enclosed for your record.

As permitted, this letter is being submitted under Sd/- mode due to work from home as per the Government advisory on Covid-19 and as a part of safety measure.

You are requested to please take the above information on your records.

Thanking you,

For Quick Heal Technologies Limited

Sd/-

A. Srinivasa Rao Company Secretary

Encl: As above

www.quickheal.co.in

Quick Heal Technologies Limited

Notes forming part of Consolidated financial statements for the period ended September 30, 2020 (All amounts are in ₹ millions, unless otherwise stated)

List of related parties as per the requirements of Ind-AS 24 - Related Party Disclosures	List of related parties as per the requirements of Ind-AS 24 - Related Party Disclosures
Relatedparties with whom transactions have takenplace during theperiod
	Kailash Katkar, Managing Director, Chief Executive Officer and ultimate holding shareholder
	Sanjay Katkar, Joint Managing Director, Chief Technical Officer and ultimate holding shareholder
	Vijay Mhaskar, Chief Operating Officer (upto October 11, 2019)
	Nitin Kulkarni, Chief Financial Officer
	Srinivasa Rao Anasingaraju, Company Secretary (w.e.f. May 10, 2019)
Key management personnel	Amitabha Mukhopadhyay , Independent Director (w.e.f June 10, 2019)
	Apurva Joshi, Independent Director
	Bhushan Gokhale, Independent Director (w.e.f. August 12, 2020)
	Mehul Savla, Independent Director
	Priti Rao, Independent Director (upto June 01, 2020)
	Shailesh Lakhani,Non-Executive Director
Relatives of key managementpersonnel	Anupama Katkar (wife of Kailash Katkar and ultimate holding shareholder)Chhaya Katkar (wife of Sanjay Katkar and ultimate holding shareholder)Sneha Katkar(daughter of Kailash Katkar and ultimate holdingshareholder)
	Kailash Sahebrao Katkar HUF
Enterprises owned by directors or	Sanjay Sahebrao Katkar HUF
major shareholders	Quick Heal Foundation
	Dreambook Production(OPC)Private Limited
Transactions with related parties and year end balances:
Nature of transaction	Name of the related party	Period endedSeptember 30, 2020	Year endedMarch 31, 2020
	Kailash Katkar	7.32	13.29
	Sanjay Katkar	7.32	13.13
Compensation paid to KeyManagement Personnel	Nitin KulkarniVijay MhaskarSrinivasa Rao Anasingaraju	-3.182.13	6.925.703.27
	Anupama Katkar	2.54	4.41
	Sneha Katkar	0.70	0.95
Sub-total		23.20	47.67
	Amitabha Mukhopadhyay	0.14	0.28
Directors' sitting fee	Apurva JoshiMehul Savla	0.100.12	0.320.22
	Priti Rao	0.07	0.28
Sub-total		0.43	1.10
	Amitabha Mukhopadhyay	-	0.60
Commission to independent	Apurva Joshi	-	0.45
directors	Mehul Savla	-	0.45
	Priti Rao	-	0.45
Sub-total		-	1.95
Total		23.63	50.72
Compensation of key managerial personal of the Company
Particulars		Period ended	Year ended
		September 30, 2020	March 31, 2020
Short-term employee benefits (compensation)		23.20	47.67
Post - employment gratuity benefits		4.34	4.18
Leave benefits		0.24	0.04
Share-basedpayment transactions		-	-
Total compensation to key management personnel		27.78	51.89

• The amounts disclosed in the table are the amounts recognised as an expense during the reporting period related to key management personnel. The remuneration and perquisites on account of ESOP to key management personnel does not include employee stock compensation expense. The non-executive and independent directors do not receive gratuity entitlements from the Company.

(This space is intentionally left blank)

Quick Heal Technologies Limited

Notes forming part of Consolidated financial statements for the period ended September 30, 2020 (All amounts are in ₹ millions, unless otherwise stated)

Share options held by executive members of the Board of Directors under the Share Based Payment arrangement to purchase equity shares have the following expiry dates and exercise prices:

			September 30, 2020	March 31, 2020
Grant Date	**Expiry Date ***	Exercise Price	**Number outstanding **	Number outstanding
February 6, 2014		**-**96.25	-	-
September 6, 2014		**-**110.00	-	-
September 24, 2015		**-**110.00	-	-
November 11, 2016		**-**237.40		62,500
October 10, 2018		**-**185.60	25,000	25,000
* As per the Company policy, the option stands cancel or expire if the employee has not exercised the option within six months from			the date of resignation.
Nature of transaction	Name of the related party		Period endedSeptember 30, 2020	Year endedMarch 31, 2020
Rent paid	Kailash KatkarSanjaySahebrao Katkar HUF		0.430.32	1.021.20
			0.75	2.22
CSR contribution	Quick Heal Foundation		19.30	22.85
			19.30	22.85
Final equitydividenddeclared	Kailash Katkar		-	37.59
and paid for the financial period	Sanjay Katkar		-	37.59
ended September 30, 2020 and	Anupama Katkar		-	9.17
March 31, 2019	Chhaya Katkar		-	9.17
			-	93.52
Interim equity dividend declared	Kailash Katkar		-	75.18
and paid for the financial period	Sanjay Katkar		-	75.18
ended September 30, 2020 and	Anupama Katkar		-	18.34
March 31, 2020	Chhaya Katkar		-	18.34
			-	187.04

Terms and conditions of transactions with related parties

The sales to and purchases from related parties are made on terms equivalent to those that prevail in arm’s length transactions. Outstanding balances at the period-end are unsecured and interest free and settlement occurs in cash. For the period ended September 30, 2020, the Company has not recorded any impairment of receivables relating to amounts owed by related parties (March 31, 2020: ` Nil). This assessment is undertaken each financial year through examining the financial position of the related party and the market in which the related party operates.

Balance outstanding

Balance outstanding
Nature of transaction	Name of the related party	As atSeptember 30,	2020		As atMarch 31, 2020
	Amitabha Mukhopadhyay		-		0.60
Commission payable to	Apurva Joshi		-		0.45
independent directors	Mehul Savla		-		0.45
	Priti Rao		-		0.45
				-	1.95